CN Patent

CN1169520C — 多孔微粒及其使用方法

Assigned to Novartis AG · Expires 2004-10-06 · 22y expired

What this patent protects

提供了向患者呼吸道输送生物活性剂的经加工的颗粒。该颗粒可以采用干粉形式或采用由一种非水连续相构成的稳定的分散体形式使用。特别优选的具体实施方案是该颗粒可以与一种吸入装置一起使用，例如干粉吸入器、计量的剂量吸入器或者喷雾器。

USPTO Abstract

提供了向患者呼吸道输送生物活性剂的经加工的颗粒。该颗粒可以采用干粉形式或采用由一种非水连续相构成的稳定的分散体形式使用。特别优选的具体实施方案是该颗粒可以与一种吸入装置一起使用，例如干粉吸入器、计量的剂量吸入器或者喷雾器。

Drugs covered by this patent

pramipexole-dihydrochloride (PRAMIPEXOLE DIHYDROCHLORIDE)

Patent Metadata

Patent number: CN1169520C
Jurisdiction: CN
Classification: —
Expires: 2004-10-06
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.